Jubilant Pharmova Limited (JUBLPHARMA) - Total Liabilities

Latest as of September 2025: Rs69.50 Billion INR ≈ $751.56 Million USD

Based on the latest financial reports, Jubilant Pharmova Limited (JUBLPHARMA) has total liabilities worth Rs69.50 Billion INR (≈ $751.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jubilant Pharmova Limited - Total Liabilities Trend (2004–2025)

This chart illustrates how Jubilant Pharmova Limited's total liabilities have evolved over time, based on quarterly financial data. See Jubilant Pharmova Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Jubilant Pharmova Limited Competitors by Total Liabilities

The table below lists competitors of Jubilant Pharmova Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Guangdong Baolihua New Energy Stock Co LTD SHE:000690	China	CN¥8.83 Billion
Zhuhai Orbita Control Eng SHE:300053	China	CN¥800.68 Million
Hunan Nanling Industrial Explosive Materials Co Ltd SHE:002096	China	CN¥3.87 Billion
Jindal Saw Limited NSE:JINDALSAW	India	Rs94.03 Billion
Bestway Marine & Energy Technology Co Ltd SHE:300008	China	CN¥3.30 Billion
Shenzhen Click Technology Co Ltd SHE:002782	China	CN¥2.58 Billion
Suning Commerce Group Co Ltd SHE:002024	China	CN¥99.66 Billion
Jyoti CNC Automation Limited NSE:JYOTICNC	India	Rs12.67 Billion

Liability Composition Analysis (2004–2025)

This chart breaks down Jubilant Pharmova Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see JUBLPHARMA stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.66	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jubilant Pharmova Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jubilant Pharmova Limited (2004–2025)

The table below shows the annual total liabilities of Jubilant Pharmova Limited from 2004 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs65.18 Billion ≈ $704.88 Million	+6.37%
2024-03-31	Rs61.27 Billion ≈ $662.66 Million	+6.29%
2023-03-31	Rs57.65 Billion ≈ $623.45 Million	+23.33%
2022-03-31	Rs46.74 Billion ≈ $505.53 Million	+11.92%
2021-03-31	Rs41.77 Billion ≈ $451.68 Million	-39.63%
2020-03-31	Rs69.18 Billion ≈ $748.13 Million	+3.88%
2019-03-31	Rs66.59 Billion ≈ $720.20 Million	+19.29%
2018-03-31	Rs55.83 Billion ≈ $603.74 Million	-1.09%
2017-03-31	Rs56.44 Billion ≈ $610.37 Million	-6.52%
2016-03-31	Rs60.37 Billion ≈ $652.93 Million	-2.29%
2015-03-31	Rs61.79 Billion ≈ $668.20 Million	+1.69%
2014-03-31	Rs60.76 Billion ≈ $657.11 Million	+4.29%
2013-03-31	Rs58.26 Billion ≈ $630.07 Million	+6.96%
2012-03-31	Rs54.47 Billion ≈ $589.09 Million	+1.82%
2011-03-31	Rs53.50 Billion ≈ $578.56 Million	+16.67%
2010-03-31	Rs45.85 Billion ≈ $495.88 Million	-14.07%
2009-03-31	Rs53.36 Billion ≈ $577.07 Million	+80.69%
2008-03-31	Rs29.53 Billion ≈ $319.38 Million	+26.36%
2007-03-31	Rs23.37 Billion ≈ $252.75 Million	+93.04%
2006-03-31	Rs12.11 Billion ≈ $130.93 Million	+59.66%
2005-03-31	Rs7.58 Billion ≈ $82.00 Million	+14.92%
2004-03-31	Rs6.60 Billion ≈ $71.36 Million	--

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.70 Billion

Rs157.02 Billion INR

Market Cap Rank

#6896 Global

#308 in India

Share Price

Rs991.35

Change (1 day)

+1.49%

52-Week Range

Rs807.65 - Rs1236.30

All Time High

Rs1269.00